CTRE
CareTrust REIT, Inc.
NYSE · Real Estate · REIT - Healthcare Facilities · US
$35.84
−1.94%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 543.4M | 476.6M | 228.3M | 198.6M | 187.5M |
| Cost of Revenue | 130.2M | 194.8M | 13.6M | 9.6M | 9.4M |
| Gross Profit | 413.2M | 281.8M | 214.7M | 189.0M | 178.1M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | (5.0M) | 138.0K | 27.9M | 20.9M | 19.3M |
| General & Admin Expense | (5.0M) | 138.0K | 27.9M | 20.9M | 19.3M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 74.7M | (38.5M) | 62.8M | 52.1M | 55.1M |
| Total Operating Expenses | 69.8M | (38.4M) | 90.7M | 73.0M | 74.3M |
| Cost and Expenses | 200.0M | 156.4M | 104.2M | 82.6M | 83.7M |
| Operating Income (EBIT) | 343.4M | 320.1M | 124.1M | 116.0M | 103.8M |
| Non-Operating | |||||
| Interest Income | 33.8M | 11.5M | 68.0M | 19.2M | 8.6M |
| Interest Expense | 50.6M | 43.7M | 30.3M | 40.9M | 30.0M |
| Net Interest Income | (16.7M) | (32.2M) | 37.7M | (21.7M) | (21.4M) |
| Other Non-Op Income/Expense | 20.3M | 5.1M | 344.0K | (62.3M) | (111.3M) |
| Non-Operating Income (excl Interest) | (70.9M) | (48.9M) | (30.7M) | 21.4M | 81.3M |
| EBT (Pre-Tax Income) | 363.7M | 325.3M | 124.4M | 53.7M | (7.5M) |
| Income Tax Expense | 8.8M | 5.0M | — | — | — |
| Bottom Line | |||||
| Net Income | 355.4M | 320.5M | 125.1M | 53.7M | (7.5M) |
| Earnings from Cont. Ops | 354.9M | 320.3M | 124.4M | 53.7M | (7.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 354.9M | 319.8M | 124.6M | 53.3M | (7.9M) |
| Per Share | |||||
| Basic EPS | $1.61 | $1.57 | $0.81 | $0.50 | ($0.08) |
| Diluted EPS | $1.61 | $1.57 | $0.80 | $0.50 | ($0.08) |
| Revenue Per Share | $2.32 | $2.34 | $1.47 | $1.87 | $1.94 |
| Shares | |||||
| Basic Shares Outstanding | 233.8M | 203.6M | 154.8M | 106.0M | 96.7M |
| Diluted Shares Outstanding | 234.2M | 204.1M | 155.2M | 106.2M | 96.7M |
| Profitability Metrics | |||||
| EBITDA | 523.3M | 462.0M | 211.6M | 145.9M | 72.9M |
| D&A | 109.0M | 93.0M | 56.9M | 51.3M | 50.4M |
| EBIT | 414.3M | 369.0M | 154.7M | 94.6M | 22.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026